December 6, 2023
Protected: Nephron Bioprocessing Industry KOL Call – Dec. 5th – REPLAY
November 29, 2023
Protected: Nephron Lab/Dx Updates Post-AMP 2023 – REPLAY
November 16, 2023
Protected: 2024 Elections & Impact on Health Subsectors – Nov. 15th – REPLAY
November 7, 2023
Protected: NGS Industry KOL Call – Nov 6th – REPLAY
October 30, 2023
Protected: TCT Takeaways Call with Leading Cardiologists – Oct. 30th – REPLAY
October 12, 2023
Broader Impact of Adoption of GLP-1 Therapy for Weight Loss
October 6, 2023
Protected: Life Science Tools Industry Update – Oct. 5th – REPLAY
October 5, 2023
Protected: Survey Says: PBM Profit Drivers Continue to Shift – Sept. 22nd – REPLAY
September 18, 2023
Trends in Profitability and Compensation of PBMs and PBM Contracting Entities
September 11, 2023
Protected: Nephron Call – CVS Launches Cordavis Biosimilar Subsidiary – Sept. 8th – REPLAY
September 11, 2023
Protected: KOL Call – Impact of Medicaid Redeterminations – Sept. 8th – REPLAY
September 8, 2023
Protected: China Tools & Dx Market Update KOL Call – Sept. 8th – REPLAY
August 18, 2023
Protected: Renal Denervation: What to Expect from FDA Advisory Panel & Reimbursement Outlook – Aug 18th – REPLAY
August 18, 2023
Protected: Market Access Strategies – IQVIA & UPMC Health Plan – Aug 17th – REPLAY
August 18, 2023
Protected: KOL Views on Clinical Trials for CROs & Tools – Aug 16th – REPLAY